13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02769767 (ClinicalTrials.gov) | August 2012 | 25/4/2016 | Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis. | Association of Polymorphisms of the Interleukin-7 Receptor-a (IL-7R), Glypican 5 (GPC5), Interleukin-2 Receptor-a (IL2-RA) , Human Leukocyte Antigen Class II Beta Chain (HLA-DRB1) Genes and Treatment Response in Multiple Sclerosis (MS). | Multiple Sclerosis, Relapsing-Remitting | Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes. | Instituto Jalisciense de Cancerologia | Instituto Mexicano del Seguro Social;University of Guadalajara | Recruiting | 18 Years | 65 Years | Both | 500 | N/A | Mexico |